Hero image with Pittsburgh background https://pittplusme.org/study/1475

We're sorry. This study is closed and no longer recruiting participants.

STUDY BASICS

Have you been diagnosed with, or are you at risk for (diabetic or obese or have high blood pressure), nonalcoholic steatohepatitis (NASH)? If so, you may be eligible to participate in a study to help researchers find out whether an oral investigational medication, called Elafibranor, is safe and effective at treating and preventing disease progression and complications. Reimbursement provided.


IRB: 20160227
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/1475 and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe